137 related articles for article (PubMed ID: 32364303)
1. Monotherapy and combination therapy with acitretin for mycosis fungoides: results of a retrospective, multicentre study.
Nikolaou V; Patsatsi A; Sidiropoulou P; Chlouverakis G; Kavvalou E; Koletsa T; Economidi A; Georgiou E; Papadavid E; Rigopoulos D; Stratigos AJ; Kruger-Krasagakis SE
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2534-2540. PubMed ID: 32364303
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work?
Amitay-Laish I; Reiter O; Prag-Naveh H; Kershenovich R; Hodak E
J Dermatolog Treat; 2019 May; 30(3):258-263. PubMed ID: 29889596
[TBL] [Abstract][Full Text] [Related]
3. Acitretin for the treatment of cutaneous T-cell lymphoma.
Cheeley J; Sahn RE; DeLong LK; Parker SR
J Am Acad Dermatol; 2013 Feb; 68(2):247-54. PubMed ID: 22917895
[TBL] [Abstract][Full Text] [Related]
4. Mycosis Fungoides in Solid-Organ Transplant Recipients: A Multicenter Retrospective Cohort Study.
Amitay-Laish I; Didkovsky E; Davidovici B; Friedland R; Ben Amitai D; Landov H; Greenberger S; Ollech A; Prag Naveh H; Hodak E; Barzilai A
Dermatology; 2023; 239(6):898-905. PubMed ID: 37751718
[TBL] [Abstract][Full Text] [Related]
5. Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial.
Ortiz-Romero PL; Maroñas Jiménez L; Muniesa C; Estrach T; Servitje O; Fernández-de-Misa R; Gallardo F; Sanmartín O; Riveiro-Falkenbach E; García-Díaz N; Vega R; Lora D; Postigo C; Jiménez B; Sánchez-Beato M; Pedro Vaqué J; Rodríguez Peralto JL; de la Cámara AG; de la Cruz J; Piris Pinilla MÁ
Lancet Haematol; 2022 Jun; 9(6):e425-e433. PubMed ID: 35654076
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
7. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
Kim YH; Martinez G; Varghese A; Hoppe RT
Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
[TBL] [Abstract][Full Text] [Related]
8. Folliculotropic mycosis fungoides with follicular mucinosis--case report.
Rados J; Dobrić I; Pasić A; Loncarić D; Manola I
Acta Dermatovenerol Croat; 2006; 14(2):94-9. PubMed ID: 16859615
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A.
Amitay-Laish I; Prag-Naveh H; Dalal A; Pavlovsky L; Feinmesser M; Hodak E
Acta Derm Venereol; 2018 Nov; 98(10):951-955. PubMed ID: 30085321
[TBL] [Abstract][Full Text] [Related]
10. The different faces of mycosis fungoides: results of a single-center study.
Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
[TBL] [Abstract][Full Text] [Related]
11. Clinical Patterns and Treatment Response of Patients With Mycosis Fungoides a Retrospective Study.
Alojail HY; Alshehri H; Kaliyadan F
Cureus; 2022 Jan; 14(1):e21231. PubMed ID: 35174031
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
Phan K; Ramachandran V; Fassihi H; Sebaratnam DF
JAMA Dermatol; 2019 Mar; 155(3):335-341. PubMed ID: 30698622
[TBL] [Abstract][Full Text] [Related]
14. Multiple milia during treatment with acitretin for mycosis fungoides.
Chang A; Kuligowski ME; van de Kerkhof PC
Acta Derm Venereol; 1993 Jun; 73(3):235. PubMed ID: 8105632
[No Abstract] [Full Text] [Related]
15. Long-term control of mycosis fungoides of the hands with topical bexarotene.
Lain T; Talpur R; Duvic M
Int J Dermatol; 2003 Mar; 42(3):238-41. PubMed ID: 12653924
[TBL] [Abstract][Full Text] [Related]
16. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.
Wu PA; Huang V; Bigby ME
Br J Dermatol; 2014 May; 170(5):1015-20. PubMed ID: 24841586
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.
Tacastacas JD; Chan DV; Carlson S; Gerson SL; Dowlati A; Fu P; Lu K; Groft S; Rosenjack J; Honda K; McCormick TS; Cooper KD
JAMA Dermatol; 2017 May; 153(5):413-420. PubMed ID: 28199478
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
Ponte P; Serrão V; Apetato M
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas.
de Masson A; Guitera P; Brice P; Moulonguet I; Mouly F; Bouaziz JD; Battistella M; Madelaine I; Roux J; Ram-Wolff C; Cayuela JM; Bachelez H; Bensussan A; Michel L; Bagot M
Br J Dermatol; 2014 Mar; 170(3):720-4. PubMed ID: 24438061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]